The Certificate Program Task Force will lead the exploration into and development of a SITC Certificate Program that will ultimately provide hospitals, medical centers, third-party payers and patients with an identifiable designation for healthcare providers who can safely and effectively participate in administration of immunotherapy agents and manage patients treated with these agents.